Lifting of the approval condition for Inovelon’s indication for Lennox-Gastaut syndrome
A product-specific regulatory topic concerning the removal of approval conditions, including a specified post-marketing surveillance study, for Inovelon combination therapy for Lennox–Gastaut syndrome.
Companies1How many companies write about this.
Threads1One company can carry more than one thread here.